Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Anidulafungin in Critically Ill Patients with Invasive Candidiasis
2009-016386-28Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2009
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of anidulafungin in invasive candidiasis, sponsored by University Medical Center Groningen. Primary endpoint: Correlation of anidulafungin pharmacokinetic parameters with disease severity markers. Started Oct 2009; status: active.
02
Drugs
anidulafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on 2009-016386-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016386-28.